2 LOCAL ANAESTHETICS Egerton

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 24

LOCAL ANAESTHETICS

DR. GATHIRI
Introduction
• Local anaesthetics reversibly block impulse
conduction along nerve axons and other
excitable membranes that utilise Na channels
as the primary means of action potential
generation.
• A LA is a drug that can reversibly prevent
transmission of the nerve impulse in the region
to which it is applied without affecting
consciousness.
Contd…
• This can be used clinically to block pain
sensation or sympathetic vasoconstrictor
impulses to specific areas of the body.
Contd…
• Historically, cocaine was the 1st in 1860.
• Used as an ophthalmic anaesthetic but found
to have addicting CNS actions.
• 1905- procaine.
• Goals of producing newer Las were to reduce
local irritation and tissue damage, minimise
systemic toxicity, faster onset of action and
longer duration of action.
Basic pharmacology
chemistry
• Most LAs consist of a lipophilic group (mostly
an aromatic ring) connected by an chain-
which includes an ester or amide to an
ionizable group (usually a tertiary amine).
classification
esters amides
• Cocaine • Lidocaine/xylocaine
• Procaine • Mepivacaine
• • Bupivacaine
Tetracaine
• Etidocaine
• Benzocaine
• Prilocaine
• chloroprocaine • Ropivacaine
• Levobupivacaine
• Cinchocaine
Pharmacokinetics
• LAs are usually administered by an injection
into the area of the nerve fibres to be blocked.
• Of importance is determining the rate of offset
of anaesthesia, and the likelihood of CNS and
cardiac toxicity.
a. absorption
• Systemic absorption of injected LA from the
site of administration depends on several
factors:
 Dosage
 Site of injection
 Drug tissue binding
 Presence of vasoconstrictor substances
 Physicochemical properties of the drug
Contd…
• Application of LA to a highly vascular area eg.
Trachea results in rapid absorption and thus
higher blood levels than in a poorly perfused
area.
• Vasoconstrictor substances eg. epinephrine
reduce systemic absorption of LAs from the
depot site by decreasing blood flow in these
areas.
b. Distribution
• Amide LAs are widely distributed after IV bolus
administration.
• After an initial rapid distribution phase,
indicative of uptake into highly perfused
organs eg. Brain, liver, kidney, heart, a slower
distribution phase occurs with uptake into
moderately well perfused tissues-muscle gut.
c. Metabolism and excretion
• LAs are converted in the liver or in plasma to
more water soluble metabolites then excreted
in urine.
• Ester type LAs are hydrolysed rapidly in the
body to by butyrylcholinesterase
(pseudocholinesterase). Have a short T ½, Eg.
Less than 1 minute for procaine and
chloroprocaine.
Contd…
• Amide linkage of LAs is hydrolysed by liver
microsomal cytochrome P450.
• The metabolism varies.
• Prilocaine(fastest)>etidocaine>lidocaine>mepi
vacaine>bupivacaine(slowest).
• :. Toxicity from the amide group is likely to
occur in patients with liver disease.
Contd…
• Decreased hepatic removal of LAs should also
be anticipated in patients with reduced
hepatic blood flow.
Pharmacodynamics
A: mechanism of action
• Blockade of voltage gated sodium channels
leading to peripheral nerve blockade.
• The excitable membrane of nerve axons and
neuronal cell bodies maintains a
transmembrane potential of -90 to -60mV.
• With excitation, the Na channels open and a
fast inward Na current depolarises the
membrane toward the Na equilibrium potential
(+40mV).
Contd…
• With depolarisation, Na channels close
(inactivate) and potassium channels open.
• The outward flow repolarises the membrane
toward the potassium equilibrium potential
(-95mV).
• Repolarisation returns the Na channels to the
rested state.
Contd…
• The Las block the Na channel.
• With increased concentrations of the LA, the
threshold for excitation increases, impulse
conduction slows, the rate of rise of the AP
declines, the AP amplitude decreases and
then the ability to generate an AP is abolished.
B: actions on nerves
• Cause loss of sensation but also of motor
paralysis.
• Upon application of LA, the smaller B and C
type fibres are blocked first.
• The small type A delta fibres are blocked next.
• Pain is blocked first and motor function last.
Fibre type Fn Diameter myelination Conduction Sensitivity to
μm velocity (m/s) block

Type A Proprioception, 12-20 heavy 70-120 +


Alpha motor

Beta Touch, pressure 5-12 heavy 30-70 ++

Gamma Muscle spindles 3-6 heavy 15-30 ++

Delta Pain, 2-5 heavy 12-30 +++


temperature

Type B Preganglionic <3 light 3-15 ++++


autonomic

Type C Pain 0.4-1.2 none 0.5-2.3 ++++


Dorsal root

Sympathetic Postganglionic 0.3-1.3 none 0.7-2.3 ++++


C: effects on other excitable tissues
• LA s have weak neuromuscular blocking
effects-little clinical importance.
• Some are useful antiarrhythmic agents ant
lower concentrations.
Clinical pharmacology
• Analgesia
• Routes of admnistration: epidural, SAB,
topical, within the vicinity of the peripheral
nerve endings, major nerve trunks.
Contd…
• Choice depends on duration of action

• Short acting
• Procaine
• Chloroprocaine
Contd…
• Intermediate acting
• Lidocaine
• Mepivacaine
• Prilocaine
• Long acting
• Tetracaine
• Bupivacaine
• Etidocaine
• Ropivacaine
Additives
• Vasoconstrictors eg epinepherine and
phenylepherine.
• Good for those with short to intermediate
duration of action.
• The vasoconstrictor retards the removal of the
LA from the site.
• Decreases blood level=reduced toxicity
• Carbonates-accelerates the onset of action of LA
Toxicity
• CNS
• CVS
• Peripheral nervous system (neurotoxicity)
• Blood

You might also like